FrancophonIA/ELRC3.0 huggingface dataset:
English: Figure Q Warning: Call your healthcare professional or pharmacist if you have any problem.
Slovenian: Opozorilo: V primeru teţav pokličite vašega zdravstvenega delavca ali farmacevta.
English: Sustained remission
Slovenian: Ohranjena remisija
English: Kromeya is used to treat severe plaque psoriasis in children and adolescents aged 4 to 17 years for whom medicines applied to the skin and treatment with UV light have either not worked very well or are not suitable.
Slovenian: Zdravilo Kromeya se uporablja za zdravljenje hude luskavice v plakih pri otrocih in mladostnikih, starih od 4 do 17 let, pri katerih zdravila, ki se nanašajo na koţo in zdravljenje z UV svetlobo nista dovolj dobro delovala ali pa nista primerna.
English: • erythema multiforme (inflammatory skin rash);
Slovenian: • multiformni eritem (vnetje koţnega izpuščaja);
English: Myocardial infarction arrhythmia, congestive heart failure
Slovenian: pogosti tahikardija občasni miokardni infarkt aritmija, kongestivno srčno popuščanje
English: Do not shake the syringe.
Slovenian: Brizge ne stresajte.
English: Your healthcare provider should show you how to prepare and inject Kromeya properly using the vial kit before you use it for the first time.
Slovenian: Vaš zdravstveni delavec vam mora pokazati kako pravilno pripraviti in injicirati zdravilo Kromeya preden boste komplet z vialo prvič uporabili.
English: • a sharps disposal container.
Slovenian: • zbiralnik za ostre predmete.
English: Kromeya is used to treat psoriatic arthritis in adults.
Slovenian: Zdravilo Kromeya se uporablja za zdravljenje psoriatičnega artritisa pri odraslih.
English: Erythema multiforme Stevens-Johnson syndrome angioedema cutaneous vasculitis lichenoid skin reaction
Slovenian: alopecija srbenje občasni nočno potenje, brazgotinjenje redki multiformni eritem sindrom Stevens-Johnson, angioedem koţni vaskulitis lihenoidna reakcija neznana pogostnost poslabšanje simptomov dermatomiozitisa
English: Patients should be instructed to seek medical advice if signs/symptoms suggestive of a tuberculosis infection (e.g. persistent cough, wasting/weight loss, low grade fever, listlessness) occur during or after therapy with Kromeya.
Slovenian: Bolnikom je treba naročiti, naj poiščejo zdravniško pomoč, če med zdravljenjem z zdravilom Kromeya ali po njem doţivijo znake/simptome, ki nakazujejo tuberkulozno okuţbo (npr. trdovraten kašelj, hujšanje/izgubljanje teţe, nekoliko zvišano telesno temperaturo, ravnodušnost).
English: Hypokalaemia, uric acid increased, blood sodium abnormal, hypocalcaemia, hyperglycaemia, hypophosphataemia, dehydration
Slovenian: Presnovne in prehranske motnje zelo pogosti zvišanje lipidov pogosti hipokalemija, hiperurikemija, nenormalni nivo natrija v krvi, hipokalcemija, hiperglikemija, hipofosfotemija, dehidracija
English: Your healthcare provider should show you how to prepare and inject Kromeya properly using the pre-filled syringe before you use it for the first time.
Slovenian: Vaš zdravstveni delavec vam mora pokazati kako pravilno pripraviti in injicirati zdravilo Kromeya preden boste napolnjeno injekcijsko brizgo prvič uporabili.
English: Excipients: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, mannitol, sodium chloride, citric acid monohydrate, sodium citrate, polysorbate 80, sodium hydroxide and water for injections.
Slovenian: Pomoţne snovi: natrijev dihidrogenfosfat dihidrat, dinatrijev fosfat dihidrat, manitol, natrijev klorid, monohidrat citronske kisline, natrijev citrat, polisorbat 80, natrijev hidroksid in voda za injekcije.
English: You should record the date when the syringe is first removed from refrigerator, and the date after which it should be discarded.
Slovenian: Zapisati si morate datum, ko je bila brizga vzeta iz hladilnika in datum, po katerem jo je potrebno zavreči.
English: Following subcutaneous administration of 40 mg of adalimumab every other week in adult rheumatoid arthritis (RA) patients the mean steady-state trough concentrations were approximately 5 µg/mL (without concomitant methotrexate) and 8 to 9 µg/mL (with concomitant methotrexate), respectively.
Slovenian: Po subkutani uporabi 40 mg zdravila adalimumab vsak drugi teden pri odraslih bolnikih z revmatoidnim artritisom (RA) so bile povprečne najmanjše koncentracije v stanju dinamičnega ravnovesja pribliţno 5 μg/ml (brez sočasne uporabe metotreksata) in od 8 do 9 μg/ml (s sočasno uporabo metotreksata).
English: In CD study I, 299 TNF-antagonist naive patients were randomised to one of four treatment groups; placebo at weeks 0 and 2, 160 mg adalimumab at week 0 and 80 mg at week 2, 80 mg at week 0 and 40 mg at week 2, and 40 mg at week 0 and 20 mg at week 2.
Slovenian: V študiji Crohnove bolezni I je bilo 299 bolnikov, ki še niso prejemali TNF-antagonistov, randomiziranih v eno od štirih skupin; placebo v 0. in 2. tednu, 160 mg adalimumaba v 0. tednu in 80 mg v 2. tednu, 80 mg v 0. tednu in 40 mg v 2. tednu in 40 mg v 0. tednu in 20 mg v 2. tednu.
English: Ped ACR 30 response (n/N)
Slovenian: Faza Odprta uvajalna faza 16 tednov Odziv »Ped ACR« 30 (n/N)
English: • The expiration date on syringe has not passed (Figure K).
Slovenian: • ali se je rok uporabnosti iztekel (Slika K).
English: It is recommended that the conduct and results of these tests are recorded in the patient reminder card. Prescribers are reminded of the risk of false negative tuberculin skin test results, especially in patients who are severely ill or immunocompromised.
Slovenian: Zdravniki se morajo zavedati tveganja za laţno negativne izvide tuberkulinskega koţnega testa, zlasti pri hudo bolnih ali imunsko oslabelih bolnikih.
English: Kromeya 40 mg solution for injection in pre-filled syringe Kromeya 40 mg solution for injection in pre-filled pen
Slovenian: Kromeya 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Kromeya 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
English: • Do not use an Kromeya pre-filled pen that has been frozen or left in direct sunlight.
Slovenian: • Zdravila Kromeya napolnjen injekcijski peresnik ne uporabljajte, če je bil injekcijski peresnik zamrznjen ali dlje časa izpostavljen neposredni sončni svetlobi.
English: In adult patients with psoriasis, the mean steady-state trough concentration was 5 µg/mL during adalimumab 40 mg every other week monotherapy treatment.
Slovenian: Pri odraslih bolnikih s psoriazo je bila povprečna koncentracija v stanju dinamičnega ravnovesja med monoterapijo z adalimumabom 40 mg vsak drugi teden 5 μg/ml.
English: • polyarticular juvenile idiopathic arthritis,
Slovenian: • poliartikularni juvenilni idiopatski artritis,
English: Kromeya is injected under the skin (subcutaneous use).
Slovenian: Zdravilo Kromeya se injicira pod koţo (subkutana uporaba).
English: • The name on the pre-filled pen says Kromeya (Figure I).
Slovenian: • je na injekcijskem peresu ime Kromeya (Slika I).
English: Kromeya is used to treat ulcerative colitis in adults.
Slovenian: Zdravilo Kromeya se uporablja za zdravljenje ulceroznega kolitisa pri odraslih.
English: Pancreatitis, dysphagia, face oedema
Slovenian: • hud izpuščaj, koprivnico
English: Keep the pre-filled syringe or pre-filled pen in its outer carton in order to protect from light.
Slovenian: Napolnjeno injekcijsko brizgo ali napolnjen injekcijski peresnik shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: The recommended Kromeya dose for patients with plaque psoriasis from 4 to 17 years of age is based on body weight (Table 3).
Slovenian: Priporočeni odmerek zdravila Kromeya pri bolnikih s psoriazo v plakih, starih od 4 do 17 let, temelji na telesni masi (preglednica 3).
English: Double blind 32 weeks Adalimumab
Slovenian: Rezultati učinkovitosti Dvojno slepa 32 tednov Adalimumab / MTX (N = 38)
English: Front view
Slovenian: Sprednja stran
English: In the open-label extension of RA study V, the mean change from baseline at Year 10 in the modified Total Sharp Score was 10.8, 9.2 and 3.9 in patients originally randomised to methotrexate monotherapy, adalimumab monotherapy and adalimumab/methotrexate combination therapy, respectively.
Slovenian: V odprtem podaljšanju študije revmatoidnega artritisa V je bila povprečna sprememba celotne Sharpove ocene v 10. letu pri bolnikih, ki so jih na začetku randomizirali na monoterapijo z metotreksatom, monoterapijo z adalimumabom in kombinacijo adalimumaba/metotreksat, glede na izhodišče 10,8, 9,2 oz. 3,9.
English: Table 9 Radiographic mean changes over 12 months in RA study III
Slovenian: Preglednica 9: Povprečne rentgenografske spremembe v 12 mesecih študije revmatoidnega artritisa III
English: Table 8 ACR responses in RA study V (percent of patients)
Slovenian: Preglednica 8: Odzivi ACR v študiji revmatoidnega artritisa V (odstotek bolnikov)
English: Muscle spasms (including blood creatine phosphokinase increased)
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva zelo pogosti mišičnoskeletne bolečine pogosti mišični spazmi (vključno s povišano kreatin fosfokinazo v krvi)
English: Your child is advised to avoid becoming pregnant and must use adequate contraception while using Kromeya and for at least 5 months after the last Kromeya injection.
Slovenian: Za vašega otroka je priporočljivo, da ne zanosi in uporablja ustrezno kontracepcijsko zaščito, dokler uporablja zdravilo Kromeya in še 5 mesecev po zadnjem injiciranju zdravila Kromeya.
English: 3.6 Turn over the vial and syringe, firmly hold the vial adapter and unscrew the syringe from the vial adapter.
Slovenian: 3.6 Vialo in injekcijsko brizgo obrnite, trdno primite nastavek za vialo in injekcijsko brizgo odvijte iz nastavka.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Slovenian: Podrobnejše informacije o tem zdravilu so na voljo na spletni strani Evropske Agencije za zdravila http://www.ema.europa.eu.
English: 7.1 Throw away your used syringe in a sharps disposal container right away after use (Figure U).
Slovenian: 7.1 Uporabljeno injekcijsko brizgo takoj zavrzite v zbiralnik za ostre predmete (Slika U).
English: • inflammation of the skin (such as eczema);
Slovenian: • vnetje koţe (kot je ekcem);
English: The double-blind period is followed by an openlabel (OL) period during which patients received 24 mg/m2 BSA of adalimumab up to a maximum of 40 mg every other week subcutaneously for up to an additional 192 weeks.
Slovenian: Obdobju dvojno slepega preskušanja je sledilo obdobje odprtega preskušanja, v katerem so bolniki prejemali 24 mg/m telesne površine adalimumaba do največjega posamičnega odmerka 40 mg vsak drugi teden subkutano do največ 192 tednov.
English: The blinded period was followed by an open−label period during which patients received adalimumab 40 mg every other week subcutaneously for up to an additional 28 weeks.
Slovenian: Slepljenemu obdobju je sledilo odprto obdobje, med katerim so bolniki dobivali 40 mg adalimumaba vsak drugi teden subkutano, do največ dodatnih 28 tednov.
English: Placebo N=162
Slovenian: Odziv placebo n = 162
English: Warning: Do not use if damaged.
Slovenian: Opozorilo: Če so pripomočki poškodovani, jih ne smete uporabljati.
English: In controlled Phase 3 trials of adalimumab in patients with plaque psoriasis with a control period duration ranging from 12 to 24 weeks, ALT elevations ≥ 3 x ULN occurred in 1.8% of adalimumabtreated patients and 1.8% of control-treated patients.
Slovenian: V kontroliranih preskušanjih faze 3 z adalimumabom pri bolnikih s psoriazo v plakih in s trajanjem kontrolnega obdobja od 12 do 24 tednov, se je zvišanje ALT ≥ 3 x ULN pojavilo pri 1,8 % bolnikov, zdravljenih z adalimumabom, in pri 1,8 % bolnikov v kontrolni skupini.
English: 40 mg Adalimumab every other week
Slovenian: 40 mg adalimumaba vsak drugi teden
English: Kromeya 40 mg/0.8 mL injection adalimumab
Slovenian: Kromeya 40 mg/0,8 ml injekcija adalimumab s.c.
English: Kromeya is used to treat moderate to severe plaque psoriasis in adults.
Slovenian: Zdravilo Kromeya se uporablja za zdravljenje zmerne do hude luskavice (psoriaze) v plakih pri odraslih.
English: • Keep all components of the Kromeya Vial Kit and the sharps disposal container out of reach and sight of children.
Slovenian: • Pripomočke zdravila Kromeya komplet z vialo in zbiralnik za ostre predmete shranjujte nedosegljivo otrokom.
English: 40 mg adalimumab administered every other week c
Slovenian: 40 mg adalimumaba vsak drugi teden c
English: Adalimumab 40 mg eow N=108 n (%)
Slovenian: Adalimumab 40 mg vsak 2. teden n = 108 n (%)
English: • The expiration date on the pre-filled pen has not passed (Figure I).
Slovenian: • ali se je rok uporabnosti iztekel (Slika I).
English: 4.1 Choose an injection site (Figure L) on:
Slovenian: 4.1 Izberite mesto injiciranja (Slika L) na: zgornjem delu stegen.
English: • Store the pre-filled syringe in a refrigerator between 2°C to 8°C.
Slovenian: • Napolnjeno brizgo shranjujte v hladilniku pri temperaturi med 2 °C in 8 °C.
English: Table 11 Radiographic mean changes over 12 months in RA study III
Slovenian: Preglednica 11: Povprečne rentgenografske spremembe v 12 mesecih študije revmatoidnega artritisa III
English: Kromeya is available as a vial, a pre-filled syringe and as a pre-filled pen.
Slovenian: Zdravilo Kromeya je lahko na voljo kot viala, napolnjena injekcijska brizga in napolnjen injekcijski peresnik.
English: - The other ingredients are sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, mannitol, sodium chloride, citric acid monohydrate, sodium citrate, polysorbate 80, sodium hydroxide and water for injections.
Slovenian: • Druge sestavine zdravila so natrijev dihidrogenfosfat dihidrat, dinatrijev fosfat dihidrat, manitol, natrijev klorid, monohidrat citronske kisline , natrijev citrat, polisorbat 80, natrijev hidroksid in voda za injekcije.
English: If a faster response is required, your doctor may prescribe an initial dose of 160 mg (as four 40 mg injections in one day or two 40 mg injections per day for two consecutive days) followed by 80 mg (as two 40 mg injections in one day) two weeks later.
Slovenian: Če je potreben hitrejši odziv, lahko zdravnik vašemu otroku predpiše začetni odmerek 160 mg (kot štiri 40 mg injekcije v enem dnevu ali kot dve 40 mg injekciji na dan dva zaporedna dneva), ki mu sledi 80 mg (kot dve 40 mg injekciji v enem dnevu) dva tedna kasneje.
English: Initial dose of 80 mg (as two 40 mg injections), followed by 40 mg every other week starting one week after the initial dose.
Slovenian: Začetni odmerek je 80 mg (kot dve 40 mg injekciji), čemur sledi odmerek 40 mg, ki se ga daje vsaka dva tedna, z začetkom en teden po začetnem odmerku.
English: If you become pregnant, you should see your doctor.
Slovenian: Če zanosite , je potrebno obiskati zdravnika.
English: 3.1 Peel open the syringe packaging and grab the syringe by the barrel.
Slovenian: 3.1 Odprite ovojnino injekcijske brizge in brizgo primite za tulec.
English: Kromeya is administered by subcutaneous injection.
Slovenian: Zdravilo Kromeya se uporablja kot subkutana injekcija.
English: Injection button
Slovenian: Injekcijska brizga
English: In adult patients with uveitis, a loading dose of 80 mg adalimumab on week 0 followed by 40 mg adalimumab every other week starting at week 1, resulted in mean steady-state concentrations of approximately 8 to 10 µg/mL.
Slovenian: Pri odraslih bolnikih z uveitisom je polnilni odmerek 80 mg adalimumaba v 0. tednu, ki mu je sledil odmerek 40 mg adalimumaba vsak drugi teden z začetkom v 1. tednu, povzročil povprečno koncentracijo v stanju dinamičnega ravnovesja pribliţno 8 do 10 µg/ml.
English: Syringe
Slovenian: Dojenje
English: Adalimumab treated patients showed statistically significant improvements at week 26 compared with placebo in the DLQI.
Slovenian: Pri bolnikih, zdravljenih z adalimumabom, je prišlo do statistično značilnega izboljšanja dermatološkega indeksa kakovosti ţivljenja (DLQI) po 26 tednih v primerjavi s placebom.
English: CD study I and CD study II induction of remission and response rates are presented in Table 20.
Slovenian: Stopnje indukcije remisije in odziva v študiji Crohnove bolezni I in študiji Crohnove bolezni II so prikazane v preglednici 20.
English: Glucocorticoids, salicylates, nonsteroidal anti-inflammatory drugs, or analgesics can be continued during treatment with Kromeya.
Slovenian: Med zdravljenjem z zdravilom Kromeya je mogoče nadaljevati z uporabo glukokortikoidov, salicilatov, nesteroidnih protivnetnih zdravil ali analgetikov.
English: Warning: Do not use the pre-filled pen if the liquid contains particles, or is cloudy or if it is colored, or has flakes in it or shows any sign of damage.
Slovenian: Opozorilo: Injekcijske brizge ne uporabljajte, če tekočina vsebuje delce, je motna ali obarvana ali če vsebuje kosmiče.
English: A loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 µg/mL during the induction period.
Slovenian: Polnilni odmerek 160 mg adalimumaba na 0. teden, ki mu sledi 80 mg adalimumaba 2. teden, doseţe med obdobjem indukcije najmanjšo koncentracijo v serumu pribliţno 12 µg/ml.
English: The recommended dose of Kromeya for adult patients is an initial dose of 80 mg administered subcutaneously, followed by 40 mg subcutaneously given every other week starting one week after the initial dose.
Slovenian: Priporočeno odmerjanje zdravila Kromeya za odrasle bolnike je začetni odmerek 80 mg subkutano in nato 40 mg subkutano vsak drugi teden, začenši en teden po začetnem odmerku.
English: If this dose does not work well enough, your child's doctor may increase the dose frequency to 20 mg every week.
Slovenian: Če ta odmerek ne bo deloval dovolj dobro, lahko otrokov zdravnik poveča pogostnost odmerjanja na 20 mg vsak teden.
English: • The glass syringe is not cracked or broken (Figure H).
Slovenian: • je steklena injekcijska brizga nepoškodovana (Slika H).
English: Warning: Gloves do not replace the need for washing hands.
Slovenian: Opozorilo: Roke si morate umiti tudi v primeru uporabe rokavic.
English: If this dose does not work well enough, your doctor may increase the dose frequency to 20 mg every week.
Slovenian: Če ta odmerek ne bo deloval dovolj dobro, mu lahko njegov zdravnik poveča pogostnost odmerjanja na 20 mg vsak teden.
English: Warning: Do not touch the syringe tip.
Slovenian: Opozorilo: Ne dotikajte se konice injekcijske brizge.
English: In controlled Phase 3 trials of adalimumab in patients with rheumatoid arthritis and psoriatic arthritis with a control period duration ranging from 4 to 104 weeks, ALT elevations ≥ 3 x ULN occurred in 3.7% of adalimumab-treated patients and 1.6% of control-treated patients.
Slovenian: V kontroliranih preskušanjih faze 3 z adalimumabom pri bolnikih z revmatoidnim artritisom in psoriatičnim artritisom s trajanjem kontrolnega obdobja od 4 do 104 tedne, so se zvišanja ALT ≥ 3 x ULN (Upper Limits of Normal - zgornja normalna meja) pojavila pri 3,7 % bolnikov, zdravljenih z adalimumabom, in pri 1,6 % bolnikov v kontrolni skupini.
English: Paraesthesias (including hypoaesthesia), migraine, nerve root compression
Slovenian: zelo pogosti glavobol pogosti parestezije (vključno s hipoastezijo), migrena, stisnjenje ţivčnih korenin občasni moţgansko-ţilni dogodki
English: Do not use this medicine after the expiry date which is stated on the label /carton after EXP.
Slovenian: Tega zdravila Kromeya ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki/ škatlici poleg oznake “EXP”.
English: Your healthcare provider should show you how to prepare and inject Kromeya properly using the pre-filled pen before you use it for the first time.
Slovenian: Vaš zdravstveni delavec vam pokazati, kako pravilno pripraviti in injicirati zdravilo Kromeya preden boste napolnjen injekcijsko peresnik prvič uporabili.
English: Across all treatment groups, the mean baseline PASI score was 18.9 and the baseline Physician's Global Assessment (PGA) score ranged from “moderate” (53% of subjects included) to “severe” (41%) to “very severe” (6%).
Slovenian: V vseh terapevtskih skupinah je bila povprečna izhodiščna ocena PASI 18,9, izhodiščna zdravnikova globalna ocena (PGA - Physician's Global Assessment) pa je segala od "zmerne" (53 % vključenih preiskovancev) do "hude" (41 %) in "zelo hude" (6 %).
English: b p-value is from the pairwise comparison of adalimumab monotherapy and adalimumab/methotrexate combination therapy using the Mann-Whitney U test c p-value is from the pairwise comparison of adalimumab monotherapy and methotrexate monotherapy using the Mann-Whitney U test
Slovenian: Vrednost p se nanaša na parno primerjavo monoterapije z adalimumabom in kombinirane terapije z adalimumabom/metotreksatom z Mann-Whitneyevim testom U.
English: Table 8 Ped ACR 30 responses in the JIA study
Slovenian: Preglednica 8 Odzivi »Ped ACR« 30 v študiji pri juvenilnem idiopatskem artritisu Stratum
English: The safety and efficacy of adalimumab were studied in adult patients with chronic plaque psoriasis (≥ 10% BSA involvement and Psoriasis Area and Severity Index (PASI) ≥ 12 or ≥ 10) who were candidates for systemic therapy or phototherapy in randomised, double-blind studies.
Slovenian: Varnost in učinkovitost adalimumaba so v randomiziranih, dvojno slepih študijah raziskali pri odraslih bolnikih s kronično psoriazo v plakih (zajete ≥ 10 % telesne površine ter indeksom obseţnosti in izrazitosti psoriaze (PASI - Psoriasis Area and Severity Index) ≥ 12 ali ≥ 10), ki so bili kandidati za sistemsko zdravljenje ali fototerapijo.
English: Children and adolescents from 4 to 17 years of age weighing 15 kg to less than 30 kg
Slovenian: Otroci in mladostniki, stari od 4 do 17 let, ki tehtajo od 15 kg do manj kot 30 kg
English: Textured finger pad
Slovenian: Reliefno mesto za prst
English: Adalimumab/MTX 40 mg every other week
Slovenian: /MTX 40 mg vsak drugi teden
English: No malignancies were observed in 77 paediatric patients with an exposure of 80.0 patient years during a adalimumab trial in paediatric patients with chronic plaque psoriasis.
Slovenian: Pri 77 pediatričnih bolnikih v preskušanju adalimumaba pri pediatričnih bolnikih s kronično psoriazo v plakih z izpostavljenostjo 80,0 bolnikov-let, niso opazili malignomov.
English: Step 7 Throw away your Syringe
Slovenian: 7. korak Zavrzite injekcijsko brizgo
English: Assessments in Ankylosing Spondylitis b
Slovenian: Ocene pri ankilozirajočem spondilitisu (Assessments in Ankylosing Spondylitis)
English: Solution for injection 2 pre-filled syringes 2 alcohol pads 6 pre-filled syringes 6 alcohol pads
Slovenian: raztopina za injiciranje 2 napolnjeni injekcijski brizgi 2 alkoholna zloţenca 6 napolnjenih injekcijskih brizg 6 alkoholnih zloţencev
English: The combination of adalimumab as well as other TNF-antagonists and anakinra or abatacept is not recommended based upon the possible increased risk for infections, including serious infections and other potential pharmacological interactions.
Slovenian: Kombinacija adalimumaba in tudi drugih TNF antagonistov in anakinre ali abatacepta ni priporočljiva, saj temelji na moţnosti, da poveča tveganje za okuţbo, vključno z resnimi okuţbami in ostalimi potencialnimi farmakološkimi interakcijami.
English: If so, throw away the syringe in a sharps disposal container and contact your healthcare professional or pharmacist.
Slovenian: V tem primeru injekcijsko brizgo zavrzite v zbiralnik za ostre predmete in se obrnite na svojega zdravstvenega delavca ali farmacevta.
English: Table 10 ACR responses in RA study V (percent of patients)
Slovenian: Preglednica 10: Odzivi ACR v študiji revmatoidnega artritisa V (odstotek bolnikov)
English: GI haemorrhage, dyspepsia, gastroesophageal reflux disease, sicca syndrome
Slovenian: Bolezni prebavil zelo pogosti bolečine v trebuhu, navzeja in bruhanje pogosti gastrointestinalna krvavitev, dispepsija, bolezen gastroezofagealnega refluksa, Sjögrenov sindrom